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In sport disciplines with high levels of muscle damage such as an ultra-trail competition, full body compression garments (FBCG)
may have an ergogenic effect during the recovery process. The aim of the study was to assess the influence of FBCG worn for 24 h
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Abstract
immediately after a 107-km ultra-trail on delayed onset muscle soreness (DOMS), muscle damage, inflammatory and renal
response. Thirty-two athletes (19 males and 13 females; VO : 54.1 ± 5.2 ml O2/kg/min) participated in the study. The following
blood markers were analysed before, immediately after, at 24 and 48  h post-race: lactate dehydrogenase, creatine kinase, C-
reactive protein and creatinine. The glomerular filtration rate was also calculated. Delayed onset muscle soreness was evaluated
before, immediately after and at 24  h post-race. On arrival at the finishing line, athletes were randomised into one of two
recovery groups (FBCG and control group). The results showed that wearing FBCG did not influence the evolution of any of the
blood markers up to 48 h after the race (p > .05). However, FBCG group presented a lower increase in posterior leg DOMS (11.0 ± 
46.2% vs 112.3 ± 170.4%, p = .03, d = 0.8). Therefore, although FBCG is not useful for reducing muscle damage and inflammatory
response after an ultra-trail race, its use may still be recommended as a recovery method to reduce muscle soreness [Q1].
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Proper recovery following a competition enables the athlete to return to regular training earlier and, consequently, improves
long-term performance (Richard & Koehle, 2019). This fact has aroused the interest of both coaches and scientists regarding
interventions aimed at optimising the recovery process (Kellmann et al., 2018). Different recovery interventions were assessed
such as massage, stretching, cryotherapy, nutritional supplementation (i.e. branched-chain amino acids, anti-inflammatory drugs)
or clothing with specific compressive qualities (Barnett, 2006). However, most studies have assessed the influence of the different
interventions under laboratory conditions and research under real competition conditions is now required (Engel, Holmberg, &
Sperlich, 2016).
Wearing compression garments during the recovery process has been one of the strategies most commonly analysed by different
studies (Brown et al., 2017; Engel et al., 2016; Pérez-Soriano et al., 2019). Although Hill, Howatson, van Someren, Leeder, and
Pedlar (2014) found that wearing lower limb compression tights for 72 h following a simulated road marathon had no significant
effect on muscle damage and inflammatory markers, a reduction in delayed onset muscle soreness (DOMS) was observed. In this
respect, recent reviews have suggested that the use of compression garments after running has little or no effect on muscle
damage and inflammatory markers (Brown et al., 2017; Engel et al., 2016). However, most of the studies were performed using
protocols to induce damage (e.g. series of sprints, drop-jumps or eccentric exercise) (Davies, Thompson, & Cooper, 2009;
Duffield, Cannon, & King, 2010; Hill et al., 2017; Kim, Kim, & Lee, 2017) or simulated trails, half-marathons and marathons
(Bieuzen et al., 2014; Hill, Howatson, van Someren, Walshe & Pedlar, 2014; McDonnell, Cooper, Mlinar, & Mekjavic, 2018). In
addition, the type of garment worn could have an influence on the ergogenic effect and most studies have only been undertaken
on the use of compressive stockings or tights (Engel et al., 2016; Pérez-Soriano et al., 2019). The ergogenic effect of full body
compression garments (FBCG) could be greater than compressive stockings or thighs due to the higher surface covered by the
garment, so further studies with these types of garments after real competitions with high levels of muscle damage are required
(Pérez-Soriano et al., 2019).
Ultra-trail running could well be a relevant sport to assess the possible beneficial effects of compression garments during
recovery, since a very pronounced post-race increase in inflammation and muscle damage blood markers has been reported
(Hoffman, Ingwerson, Rogers, Hew-Butler, & Stuempfle, 2012; Millet et al., 2011). These high levels of inflammation and muscle
damage are as a consequence of the succession of prolonged eccentric actions that occur in the downhill sections of these races
(Giandolini, Horvais, et al., 2016; Giandolini, Vernillo, et al., 2016; Vernillo et al., 2017). An example of the levels of ultra-trail
running damage is that while 1350 U/l of circulating levels of creatine kinase (CK) were observed after a protocol of 2 sets of 50
bicep curls with 12 maximal eccentric contractions (Brown et al., 2017), CK concentrations of over 15,000 U/l have been reported
after ultra-trail races (i.e. Ultra Trail du Mont-Blanc or Western States Endurance Run) (Hoffman et al., 2012; Millet et al., 2011).
Although several studies have analysed the effect of compression garments on DOMs, inflammatory and muscle damage markers
following a simulated trail running (Bieuzen et al., 2014; McDonnell et al., 2018), there is a lack of research into their effect
following ultra-trail races.
The aim of the study, therefore, was to analyse the effect on DOMS, muscle damage, inflammatory response and renal function of




have an ergogenic effect on muscle damage, inflammatory response and DOMS.
Forty-seven recreational ultra-endurance athletes (29 males and 18 females) were recruited to participate in the study. This
research was undertaken at the Penyagolosa Trails CSP race in 2019 (Spain). The track consisted of 107.4  km, starting at an
altitude of 40  m and finishing at 1280  m above sea level, with a total positive and negative elevation of 5604 and 4356  m,
respectively. All subjects were informed of the procedure and gave their written consent to participate. They were also allowed to
withdraw from the study voluntarily. A questionnaire was used to collect demographic information as well as training and
competition history. Participants were also subjected to a cardiopulmonary exercise test and a body composition assessment
(Tanita BC-780MA, Tanita Corp., Tokyo, Japan) between 2 and 4 weeks prior to the race. The investigation was conducted
according to the Declaration of Helsinki and approval for the project was obtained from the research Ethics Committee of the
University Jaume I of Castellon (Expedient Number CD/007/2019). This study is enrolled in the ClinicalTrails.gov database, with
code number NCT03990259 (www.clinicaltrials.gov).
From the initial sample (47 athletes), 4 participants did not start the race due to injury and 32 athletes successfully completed the
race with an average finishing time of 21 h 23 min ± 3 h 28 min. The finisher/starter ratio for the subjects of the present study (i.e.
74.4%) was similar to the ratio when all race participants were considered (73.8%), whereas the average finish time was somewhat
faster when all race participants were considered (20 h 24 min ± 3 h 11 min).
Participants were randomised on their arrival at the finishing line into one of two recovery groups: (1) experimental group (FBCG),
wearing FBCG during the first 24 h following the race (thus including night sleep); and (2) control group (CG), not wearing any
compressive garments for the immediate 24 h following the race. Both groups were asked to abstain from doing any exercise
during the first 48 h post-race period. In addition, massage and use of electromyostimulation were neither allowed during this
time period. A follow-up online questionnaire was employed to verify that athletes did not use other recovery procedures during
the first 48 h post-race. Each recovery group was then formed by 16 participants (FBCG: 8 men and 8 women; CG: 11 men and 5
women). The average finishing times of FBCG and CG were 21 h 11 min ± 3 h 14 min and 21 h 33 min ± 3 h 47 min respectively
(p = 0.71; d = 0.1). The characteristics of FBCG and CG participants are presented in Table I.
 Characteristics of FBCG and CG participants (mean ± SD)
2. Methods
2.1. Participants
2.2. Full body compression garments
Table I.
Whole sample (n = 32) FBCG (n = 16) CG (n = 16)
FBCG vs. CG
p-value Cohen’s D
Age (years) 41 ± 6 41 ± 6 41 ± 6 0.66 0.2
BMI (kg/m )2 22.8 ± 2.0 22.5 ± 1.9 23.2 ± 2.1 0.33 0.4
FM (%) 15.4 ± 4.9 15.7 ± 4.7 15.1 ± 5.2 0.70 0.1
LBM (%) 80.3 ± 4.7 79.9 ± 4.5 80.7 ± 5.1 0.66 0.2
VO  (ml O /kg/min)2peak 2 54.1 ± 5.2 53.2 ± 4.2 54.9 ± 6.0 0.38 0.3
V  (km/h)MAX 15.9 ± 1.9 15.9 ± 2.0 15.9 ± 1.8 0.92 0.0
V  (km/h)VT2 13.3 ± 1.4 13.3 ± 1.4 13.3 ± 1.4 0.99 0.0
Number of years running 8 ± 3 8 ± 3 7 ± 3 0.74 0.1
Number of races >100 km 2 ± 3 3 ± 3 2 ± 3 0.78 0.1
Weekly training days 5 ± 1 5 ± 1 5 ± 1 0.65 0.2
Weekly running volume (km) 70 ± 22 71 ± 18 69 ± 26 0.80 0.1
Weekly positive elevation (m) 1772 ± 691 1650 ± 475 1894 ± 854 0.33 0.4
Note: BMI, Body Mass Index; FM, fat mass; LBM, lean body mass; VO peak , peak oxygen uptake; V , peak speed reached at the Cardiopulmonar Exercise Test;
V , speed associated with the second ventilatory threshold in the Cardiopulmonar Exercise Test; Strength training (%), percentage of participants who
performed at least one weekly strength-training in the previous 3 months.
The composition of the FBCG was 88% polyamide and 12% elastane, weighing 345 g, and with a graduated compression of 10–
15 mmHg according to the manufacturer’s specifications and validated at the Textile Research Institute (AITEX , Spain) using
Medical Stocking Tester technology (model MST MK IV, Salzmann Group, Switzerland).
Blood samples were collected from an antecubital vein by venipuncture the day before the race, after crossing the finishing line,
24 and 48 h post-race using BD Vacutainer PST II tubes. Samples were centrifuged at 3500 rpm for ten minutes and kept at 4°C
during transport to Vithas Rey Don Jaime Hospital (Castellon, Spain), where they were processed using the modular platform
Roche / Hitachi clinical chemistry analyser Cobas c311 (Roche Diagnostics, Penzberg, Germany), as previously published (Bernat-
Adell et al., 2019; Panizo Gonzalez et al., 2019). Lactate dehydrogenase (LDH) and CK were used as muscle damage markers, C-
reactive protein (CRP) as an indicator of acute inflammatory reaction, and creatinine as a marker of renal function. The Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to calculate the glomerular filtration rate (GFR) (Levey
et al., 2009). Biochemical results obtained immediately post-race were adjusted by employing the Dill and Costill method (Dill &
Costill, 1974), using haematocrit and haemoglobin to determine the magnitude of plasma volume changes after the race in each
participant (Alis et al., 2015; Dill & Costill, 1974).
DOMS was recorded using a visual analogue scale (VAS) the day before the race, within 10 min after crossing the finishing line
and 24 h post-race. The VAS consisted of a 10-cm horizontal line, the endpoints of which were labelled as ‘no pain’ (0 cm) and
‘extreme pain’ (10 cm). The VAS, has been shown to be valid and reliable in previous research (Cleather & Guthrie, 2007), and is
commonly used to detect DOMS (Nakagawa et al., 2018; Tojima, Noma, & Torii, 2016; Wiewelhove et al., 2018). Participants were
asked to palpate four different lower limb regions (anterior knee, DOMS_AK; posterior knee, DOMS_PK; anterior leg, DOMS_AL;
posterior leg, DOMS_PL) and then mark a vertical line at the point on the scale that best represented the amount of muscle pain
at the time of the measurement. A global value (DOMS_G) was also recorded as an overall participant perception of full body
muscle pain. Scores were determined from the distance in cm from the left border of the scale to the point marked (Cleather &
Guthrie, 2007).
Statistical analyses were carried out using the Statistical Package for the Social Sciences software (IBM SPSS Statistics for
Windows, version 22.0, IBM Corp., Armonk, NY, USA). Normality of the data was confirmed using Kolmogorov Smirnov test (p >
.05). A two-factor repeated-measures ANOVA was conducted, with one between-subject factor (‘Intervention’; FBCG vs CG) and
one within-subject factor (‘Time’; PRE, POST, 24 and 48 h post-race), to assess the possible effect of wearing FBCG on analytical
variables. The same procedure was employed to appraise possible differences in DOMS between the above-mentioned groups.
Whenever Mauchly’s Sphericity test was violated, necessary technical corrections were performed using the Greenhouse-Geisser
test; and for each ANOVA, if a significant main effect or interaction was identified, Bonferroni post-hoc comparisons were
conducted. Moreover, DOMS and analytical values at 24 h and analytical values at 48 h following the race, set as percentages of
post-race values, were compared between groups using unpaired Student's t-tests. In addition, the meaningfulness of the
outcomes was estimated through the partial estimated effect size (η  partial) for ANOVA and Cohen’s d effect size for pairwise
comparisons. Cohen’s D < 0.5 was considered small; between 0.5 and 0.8, moderate; and greater than 0.8, large (Cohen, 1988). The
significance level was set at p-value <.05 and data are presented as means and standard deviations (±SD).
Univariate contrast analysis showed a significant effect for ‘Time’ on creatinine [F = 73.28; p<0.01; η  partial = 0.71], GFR
[F = 88.66; p < .01; η  partial = 0.75], CK [F = 34.49; p < .01; η  partial = 0.53], LDH [F = 61.28; p < .01; η  partial = 0.67] and CRP
[F = 57.22; p < .01; η  partial = 0.66]. No ‘Intervention x Time’ interaction effects were revealed for the analytical variables (see
Table II) and Student's t-tests also presented no differences between FBCG and CG.
 Analytical variables in FBCG and CG (mean ± SD)
Weekly training hours 10 ± 4 11 ± 4 8 ± 4 0.10 0.6
Strength training (%) 81.3% 93.8% 68.8% 0.07 –
2 MAX
VT2









Note: GFR, Glomerular filtration rate; CK, Creatine kinase; LDH, Lactate dehydrogenase; CRP, C-reactive protein.
Significantly different from pre-race value.
Significantly different from post-race value.
Significantly different from 24 h post-race value.
Regarding DOMS values, univariate contrast analysis showed a significant effect for ‘Time’ on DOMS_G [F = 36.22; p < .01; η
partial = 0.55], DOMS_AK [F = 21.84; p < .01; η  partial = 0.42], DOMS_PK [F = 6.84; p < .01; η  partial = 0.19], DOMS_AL [F = 12.33;
p < .01; η  partial = 0.29] and DOMS_PL [F = 5.06; p = 0.015; η  partial = 0.14]. No ‘Intervention x Time’ interaction effects were
revealed for DOMS variables; however, Student's t-tests revealed that FBCG showed a smaller increase in DOMS_PL 24 h post-race
(11.0 ± 46.2% vs 11.3 ± 170.4%, p = .03, d = 0.8) (see Figure 1).
FBCG (n = 16) CG (n = 16)
FBCG vs. CG
p-value Cohen’s D
Pre-race cretinine (mg/dL) 1.0 ± 0.2 1.0 ± 0.1 0.62 0.2
Post-race cretinine (mg/dL) 1.3 ± 0.4a 1.3 ± 0.2a 1.00 0.0
24 h post-race cretinine (mg/dL) 1.0 ± 0.2b 1.0 ± 0.2b 1.00 0.0
48 h post-race cretinine (mg/dL) 0.9 ± 0.2c 0.9 ± 0.1c 0.83 0.1
Pre-race GFR (mL/min/1.73 m )2 73.6 ± 7.7 75.6 ± 8.6 0.48 0.3
Post-race GFR (mL/min/1.73 m )2 54.2 ± 12.4a 55.4 ± 10.1a 0.76 0.1
24 h post-race GFR (mL/min/1.73 m )2 71.9 ± 15.6b 74.3 ± 11.6b 0.62 0.2
48 h post-race GFR (mL/min/1.73 m )2 82.1 ± 17.1c 82.5 ± 8.5c 0.93 0.0
Pre-race CK (Ul/L) 179.6 ± 110.2 227.8 ± 294.9 0.55 0.2
Post-race CK (Ul/L) 4231.6 ± 2680.0a 5728.5 ± 5007.7a 0.30 0.4
24 h post-race CK (Ul/L) 2561.6 ± 2290.7a 2812.9 ± 2647.0a ,b 0.78 0.1
48 h post-race CK (Ul/L) 1425.1 ± 1671.2a ,c 1451.1 ± 1710.0a ,c 0.97 0.0
Pre-race LDH (Ul/L) 196.5 ± 31.0 182.4 ± 30.8 0.21 0.5
Post-race LDH (Ul/L) 361.6 ± 81.5a 391.2 ± 133.3a 0.46 0.3
24 h post-race LDH (Ul/L) 318.5 ± 96.4a ,b 325.7 ± 131.0a ,b 0.86 0.1
48 h post-race LDH (Ul/L) 304.3 ± 105.1a 320.0 ± 146.3a 0.73 0.1
Pre-race CRP (mg/dL) 0.2 ± 0.6 0.1 ± 0.1 0.44 0.3
Post-race CRP (mg/dL) 2.0 ± 1.4a 2.0 ± 1.1a 0.97 0.0
24 h post-race CRP (mg/dL) 3.9 ± 2.7a ,b 3.7 ± 2.4a ,b 0.79 0.1







 Relative changes 24 h post-race in DOMS variables between FBCG and CG. * Significant difference between 
groups (p < .05).
Figure 1.
The present study analysed the effect on DOMS, muscle damage, inflammatory response and renal function of wearing FBCG for
24  h immediately following a 107-km ultra-trail. It was hypothesised that runners wearing FBCG for the initial 24  h post-race
period would present less DOMS and muscle damage, and better inflammation recovery. However, although better recovery from
DOMS in posterior leg among the runners who used FBCG was observed, no effect was found on muscle damage, inflammatory
and renal function recovery.
Kraemer et al. (2001, 2010) suggested two possible mechanisms as to why compression garments might reduce the concentration
of muscle damage markers: (a) the release of damage markers would be lessened as a result of compression treatment, and (b)
compression would facilitate the clearance and removal of myofibrillar proteins. However, most previous studies assessing the
use of compression garments during recovery have shown no significant effect on muscle damage markers (Bieuzen et al., 2014;
Duffield et al., 2010; Goto & Morishima, 2014; Goto, Mizuno, & Mori, 2017; Hill et al., 2017; Hill, Howatson, van Someren, Walshe,
et al., 2014; Jakeman, Byrne, & Eston, 2010; Kim et al., 2017; Mizuno, Morii, Tsuchiya, & Goto, 2016). It has been suggested that
their effectiveness could be dependent on the magnitude of post-exercise CK and LDH concentration (Brown et al., 2017). In
addition, the need for further studies using different compressive garments, such as stockings or tights, was recommended (Pérez-
Soriano et al., 2019). Hence, considering that downhill sections in ultra-trail races involve a succession of prolonged eccentric
actions (Giandolini, Horvais, et al., 2016; Giandolini, Vernillo, et al., 2016; Vernillo et al., 2017) and large CK and LDH values have
been reported following those races (Hoffman et al., 2012; Millet et al., 2011), we hypothesised that using FBCG during recovery
would reduce muscle damage response. However, wearing FBCG after the race had no influence on the response in these markers.
Consequently, our results do not support the hypothesis proposed by Kraemer et al. (2001; 2010).
On the other hand, compression garments have also been proposed to reduce the swelling and inflammatory processes
associated with muscle damage (Kraemer, French, & Spiering, 2004). Indeed, it has been suggested that the garments work by
creating an external pressure gradient and reducing the space available for swelling to occur, thus minimising the secondary
inflammatory response (Davies et al., 2009). However, our results did not observe any reduction in CRP in those runners who wore
FBCG during post-race recovery. Moreover, this finding is in line with the most recent studies in the field (Bieuzen et al., 2014;
Duffield et al., 2010; Goto et al., 2017; Goto & Morishima, 2014; Hill et al., 2017; Hill, Howatson, van Someren, Leeder, et al., 2014;
Kim et al., 2017; Mizuno et al., 2016). It has also been suggested that the use of compression garments can improve
hemodynamics following vigorous exercise (Born, Sperlich, & Holmberg, 2013) and that exercise-induced renal alterations have
been associated with mechanisms of inflammatory origin (Panizo Gonzalez et al., 2019). Our results, nevertheless, did not show
any effect of FBCG on creatinine and GFR, and, therefore, no improvement on the recovery of renal function can be suggested. In
either case, the fact that both blood markers were normalised within 24 h after the race suggests that no long-term renal function
repercussions are expected.
The results of the our study present a positive effect of FBCG on DOMS. Moreover, the lower limb regions where the ergogenic
effect was observed (p = .03 for the posterior limb; p = .08 for the anterior knee, not mentioned in results section) are those that
have been reported to suffer greater neuromuscular fatigue following Ultra-trail races (Millet et al., 2011). This result is in
agreement with previous studies using compression garments, following protocols to induce muscle damage (Davies et al., 2009;
Duffield et al., 2010; Goto & Morishima, 2014; Jakeman et al., 2010; Kim et al., 2017; Kraemer et al., 2010) and endurance workouts
(Hill, Howatson, van Someren, Walshe, et al., 2014; McDonnell et al., 2018). In this respect, the meta-analyses review by Hill,
Howatson, van Someren, Leeder et al. (2014) revealed that, with the use of compression garments, 66% of the population is likely
4. Discussion
to experience reduced DOMS. Some authors have argued that applying compression garments during recovery from muscle-
damaging exercise enhances lymphatic outflow, thereby leading to less muscle swelling and pain and greater comfort (Born
et al., 2013; Davies et al., 2009; Kraemer et al., 2001). Despite this hypothesis, the possibility that the effect upon perceived muscle
soreness is influenced by more positive perceptions and participants’ intuitions concerning the results to be expected cannot ever
be excluded (placebo effect). Indeed, a previous study that analysed the effect of compression socks worn during the recovery
between repeated maximal running bouts observed that their ergogenic effect was further enhanced when athletes believe in its
efficacy (Brophy-Williams, Driller, Kitic, Fell, & Halson, 2017).
The use of FBCG for 24  h following an ultra-trail reduces posterior leg DOMS, but has no influence on muscle damage,
inflammatory response and renal function markers. Therefore, the positive and negative aspects of using FBCG during the
recovery process have to be weighed up. Coaches may recommend wearing FBCG to their athletes during the recovery process
for the benefits they present in reducing DOMS, especially to those runners who often complain of greater muscle soreness in the
posterior leg region following Ultra-trail races. However, for some athletes, wearing FBCG during recovery can be uncomfortable
due to pressure and thermal discomfort. In these cases, it is not recommendable to insist on wearing such garments, as they have
no effect on muscle damage and inflammatory markers.
The main limitation of this study was the possible placebo effect of FBCG on DOMS. Future studies, therefore, could use a control
condition (full garment without compression). In addition, future studies could explore other physiological (e.g. oxidative stress)
and physical variables (e.g. counter-movement jump test).
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